Tonix Pharmaceuticals to Present Poster on Tonmya(TM) at the 2025 American College of Rheumatology (ACR) Convergence GlobeNewswire October 21, 2025 CHATHAM, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated, commercial biotechnology company, announced today that a poster on Tonmya(TM) (cyclobenzaprine HCl sublingual tablets), which […]

iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek(R) and PEGS Europe 2025 GlobeNewswire October 21, 2025 SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) — iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development

Standing Behind Our Suspension Ferris Announces Two New Programs To Support Landscapers, Homeowners And Dealers Visit Briggs & Stratton at Equip Expo Booth 5016 GlobeNewswire October 21, 2025 Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Ferris is introducing a new industry-leading, 10-year suspension warranty with a 24-hour suspension parts guarantee, making this the longest

Vanguard Battery Technology Powers FIRSTGREEN Industries' Innovative MiniZ Electric Loader GlobeNewswire October 21, 2025 Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Briggs & Stratton is showcasing the power and durability of its Vanguard(TM) 48V 7kWh(1) Commercial Battery (Fi7.0) through a real-world application with its partner FIRSTGREEN Industries, an innovator in electric heavy equipment. The

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy GlobeNewswire October 21, 2025 WELLESLEY HILLS, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that it has strengthened its leadership team with

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress Charles “Chip” Romp and Tom Heyman join SynOx's Board, bringing deep launch, lifecycle, and corporate development expertise as the company advances its next-generation therapy emactuzumab toward key regulatory and commercial milestones GlobeNewswire October 21, 2025 DUBLIN and

Billy Goat Unveils Next-Generation Hurricane(TM) Stand-On Blowers: The Z3002 and X3002 GlobeNewswire October 21, 2025 Milwaukee, WI, Oct. 21, 2025 (GLOBE NEWSWIRE) — Billy Goat is pleased to announce the launch of the new Z3002 and X3002 Hurricane(TM) Stand-On Blowers. These models are built upon the robust performance of the prior 3001 series, incorporating significant

Sionna Therapeutics Announces Initiation of PreciSION CF Phase 2a Trial Evaluating NBD1 Stabilizer, SION-719, When Added to Standard of Care in Participants with Cystic Fibrosis GlobeNewswire October 21, 2025 SION-719 is the first NBD1 stabilizer being evaluated in people living with cystic fibrosis Topline data expected in mid-2026 WALTHAM, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE)

Chipmind launches from stealth with $2.5m for its AI agents to speed chip making Chipmind's technology is designed to shorten chip development cycles. Its AI agents solve real-world chip design and verification tasks autonomously, helping engineers save 40% of their time on repetitive low-level tasks. GlobeNewswire October 21, 2025 Zurich, Oct. 21, 2025 (GLOBE NEWSWIRE)

MPDV positioned as a Leader in the 2025 SPARK Matrix(TM): Manufacturing Execution Systems (MES)- Discrete by QKS Group GlobeNewswire October 21, 2025 Pune, India, Oct. 21, 2025 (GLOBE NEWSWIRE) — The QKS Group SPARK Matrix(TM) provides competitive analysis & ranking of the leading Manufacturing Execution Systems (MES)-Discrete vendors. MPDV, with its comprehensive technology and customer